103 related articles for article (PubMed ID: 7346180)
1. Methodological aspects of prophylactic drug trials in migraine.
Olesen J; Krabbe AA; Tfelt-Hansen P
Cephalalgia; 1981 Sep; 1(3):127-41. PubMed ID: 7346180
[TBL] [Abstract][Full Text] [Related]
2. Methodological aspects of drug trials in migraine.
Tfelt-Hansen P; Olesen J
Neuroepidemiology; 1985; 4(4):204-26. PubMed ID: 2872606
[TBL] [Abstract][Full Text] [Related]
3. [Ferrum quartz in the prevention of migraine. A double-blind study].
Krabbe AA; Olesen J
Ugeskr Laeger; 1980 Feb; 142(8):516-8. PubMed ID: 6989074
[No Abstract] [Full Text] [Related]
4. Methodology of drug trials in migraine.
Tfelt-Hansen P; Nielsen SL
Funct Neurol; 1986; 1(4):499-502. PubMed ID: 3609877
[TBL] [Abstract][Full Text] [Related]
5. Migraine prevention with timolol. A double-blind crossover study.
Stellar S; Ahrens SP; Meibohm AR; Reines SA
JAMA; 1984 Nov; 252(18):2576-80. PubMed ID: 6387197
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic treatment of migraine with clonidine. A controlled clinical trial.
Mondrup K; Moller CE
Acta Neurol Scand; 1977 Nov; 56(5):405-12. PubMed ID: 339659
[TBL] [Abstract][Full Text] [Related]
7. Symptoms of classic migraine attacks: modifications brought about by metoprolol.
Hedman C; Andersen AR; Andersson PG; Gilhus NE; Kangasniemi P; Olsson JE; Strandman E; Nestvold K; Olesen J
Cephalalgia; 1988 Dec; 8(4):279-84. PubMed ID: 3064920
[TBL] [Abstract][Full Text] [Related]
8. Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache.
Haas DC; Sheehe PR
Headache; 2004; 44(10):1029-37. PubMed ID: 15546268
[TBL] [Abstract][Full Text] [Related]
9. Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study.
Baldrati A; Cortelli P; Procaccianti G; Gamberini G; D'Alessandro R; Baruzzi A; Sacquegna T
Acta Neurol Scand; 1983 Mar; 67(3):181-6. PubMed ID: 6868956
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
11. L-5-hydroxytryptophan versus placebo in childhood migraine prophylaxis: a double-blind crossover study.
Santucci M; Cortelli P; Rossi PG; Baruzzi A; Sacquegna T
Cephalalgia; 1986 Sep; 6(3):155-7. PubMed ID: 3533271
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic treatment of migraine with tolfenamic acid. A comparative double-blind crossover study between tolfenamic acid and placebo.
Mikkelsen BM; Falk JV
Acta Neurol Scand; 1982 Jul; 66(1):105-11. PubMed ID: 7051739
[TBL] [Abstract][Full Text] [Related]
13. [Controlled therapeutic trials in migraine: methodology and results].
Baron JC; Bousser MG
Rev Neurol (Paris); 1982; 138(4):279-95. PubMed ID: 6753081
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic treatment of migraine].
Igarashi H
Nihon Rinsho; 2005 Oct; 63(10):1809-14. PubMed ID: 16218395
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
16. [Prophylactic treatments of migraine].
Massiou H
Rev Neurol (Paris); 2000; 156 Suppl 4():4S79-86. PubMed ID: 11139754
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
18. Drug trials in migraine. The clinician's view on end points.
Bousser MG; Baron JC
Neuroepidemiology; 1987; 6(4):228-33. PubMed ID: 3683718
[TBL] [Abstract][Full Text] [Related]
19. Patient numbers needed in prophylactic migraine trials.
Tfelt-Hansen P; Nielsen SL
Neuroepidemiology; 1987; 6(4):214-9. PubMed ID: 3683716
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
